Nominations of Topics for Evidence-based Practice Centers, 19203-19205 [07-1813]
Download as PDF
Federal Register / Vol. 72, No. 73 / Tuesday, April 17, 2007 / Notices
sponsored, overseen, or disseminated by
the Council and advise the Secretary, as
necessary, concerning such needs.
The PCPFS holds at a minimum, one
meeting in the calendar year to (1)
assess ongoing Council activities and (2)
discuss and plan future projects and
programs.
Dated: April 10, 2007.
James Scanlon,
Deputy Assistant Secretary for Planning and
Evaluation (OSDP), Office of the Assistant
Secretary for Planning and Evaluation.
[FR Doc. 07–1885 Filed 4–16–07; 8:45am]
Dated: April 12, 2007.
Melissa Johnson,
Executive Director, President’s Council on
Physical Fitness and Sports.
[FR Doc. E7–7251 Filed 4–16–07; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
BILLING CODE 4150–35–P
Nominations of Topics for Evidencebased Practice Centers
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on PROD1PC70 with NOTICES
Pursuant to the Federal Advisory
Committee Act, the Department of
Health and Human Services (HHS)
announces the following advisory
committee meeting.
Name: National Comittee on Vital and
Health Statistics (NCVHS)
Subcommittee on Privacy and
Confidentiality.
Time and Date: April 17, 2007, 9
a.m.–5 p.m.
Place: Hilton Embassy Row, 2015
Massachusetts Avenue, NW.,
Washington, DC 20036.
Status: Open.
Purpose: The purpose of this session
will be to discuss consumer controls for
sensitive health records.
For Further Information Contact:
Substantive program information as
well as summaries of meetings and a
roster of committee members may be
obtained from Maya A. Berstein, Lead
Staff for Subcommittee on Privacy and
Confidentiality, Office of the Assistant
Secretary for Planning and Evaluation,
434E Hubert H. Humphrey Building,
200 Independence Avenue, SW.,
Washington, DC 20201; telephone (202)
690–7100; or Marjorie S. Greenberg,
Executive Secretary, NcVHS, National
Center for Health Statistics, Centers for
Disease Control and Prevention, 3311
Toledo Road, Room 2402, Hyattsville,
Maryland 20782; telephone (301) 458–
4245. Information also is available on
the NCVHS home page of the HHS Web
site: https://www.ncvhs.hhs.gov/, where
further information including an agenda
will be posted when available.
Should you require reasonable
accommodation, please contact the CDC
Office of Equal Employment
Opportunity on (301) 458–4EEO (4336)
as soon as possible.
19:39 Apr 16, 2007
Jkt 211001
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Nomination of topics for
evidence reports, technology
assessments, and comparative and
effectiveness reviews.
AGENCY:
National Committee on Vital and Health
Statistics: Meeting
VerDate Aug<31>2005
BILLING CODE 4151–05–M
SUMMARY: AHRQ invites nominations of
topics for evidence reports, technology
assessments, and comparative and
effectiveness reviews conducted by its
Evidence-based Practice Centers (EPC)
Program relating to the prevention,
diagnosis, treatment and management of
common diseases and clinical
conditions, as well as topics relating to
the organization and financing of health
care. Previous evidence reports and
comparative effectiveness reviews can
be found at https://www.ahrq.gov/clinic/
epcix.htm and https://
effectivehealthcare.ahrq.gov/products/
progress.cfm, respectively.
DATES: Topic nominations for general
evidence reports should be submitted by
May 14, 2007, in order to be considered
for fiscal year 2007 selection. Topic
nominations for comparative and
effectiveness reviews are accepted on an
on going basis at: https://
effectivehealthcare.ahrq.gov/
topicNomination/
nominationsForm.cfm. In addition to
timely responses to this request for
nominations, AHRQ also accepts topic
nominations on an ongoing basis for
consideration for future years. Topics
submitted for consideration as general
evidence reports will concurrently be
considered as comparative effectiveness
reviews as appropriate. AHRQ will not
reply to individual responses, but will
consider all nominations during the
selection process. Those who submit
topics that are selected will be notified
by AHRQ.
ADDRESSES: Topics nominations should
be submitted to Beth A. Collins Sharp,
Ph.D., R.N., Director, Evidence-based
Practice Centers (EPC) Program, Center
for Outcomes and Evidence, AHRQ, 540
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
19203
Gaither Road, Rockville, MD 20850.
Electronic submissions to epc@ahrq.gov
are preferred.
FOR FURTHER INFORMATION CONTACT: Beth
A. Collins Sharp, Ph.D., R.N., Center for
Outcomes and Evidence, AHRQ, 540
Gaither Road, Rockville, MD 20850;
Phone: (301) 427–1503; Fax: (301) 427–
1640; E-mail:
beth.collinssharp@ahrq.hhs.gov.
Arrangement for Public Inspection:
All nominations will be available for
public inspection by appointment at the
Center for Outcomes and Evidence,
telephone (301) 427–1600, weekdays
between 8:30 a.m. and 5 p.m. (Eastern
time).
SUPPLEMENTARY INFORMATION:
1. Background
Under Title IX of the Public Health
Service Act, AHRQ is charged with
enhancing the quality, appropriateness,
and effectiveness of health care services
and access to such services. AHRQ
accomplishes these goals through
scientific research, including evaluative
medical literature reviews and
technology assessments, and through
the promotion of improvements in
clinical practice and health systems
practices.
2. Purpose and Overview
The purpose of this notice is to solicit
topic nominations for evidence reports,
technology assessments, and
comparative and effectiveness reviews.
Professional societies, health systems,
employers, insurers, providers, and
consumer groups are encouraged to
nominate topics and then collaborate
with AHRQ, as it carries out its mission
to promote the practice of evidencebased health care. In this endeavor,
AHRQ serves as a science partner with
private-sector and public organizations
in their efforts to improve the quality,
effectiveness, and appropriateness of
health care delivery in the United
States, and to expedite the translation of
evidence-based research findings into
improved health care services. To
undertake scientific analyses and
evidence syntheses on topics of high
priority to its public and private health
care partners and the health care
community generally, AHRQ awards
task order contracts to its Evidencebased Practice Centers (EPCs).
The EPCs produce systematic reviews
of the scientific literature—evidence
reports, technology assessments, and
comparative and effectiveness reviews—
that provide to public and private
organizations the foundation for
developing and implementing their own
practice guidelines, performance
E:\FR\FM\17APN1.SGM
17APN1
19204
Federal Register / Vol. 72, No. 73 / Tuesday, April 17, 2007 / Notices
sroberts on PROD1PC70 with NOTICES
measures, educational programs, and
other strategies to improve the quality of
health care and decision-making related
to the effectiveness and appropriateness
of specific health care technologies and
services. The evidence reports,
technology assessments, and
comparative and effectiveness reviews
also may be used to inform coverage and
reimbursement policies. As the body of
scientific studies related to organization
and financing of health care grows,
systematic review and analysis of these
studies, in addition to clinical and
behavioral research, can provide health
system organizations with a scientific
foundation for developing or improving
system-wide policies and practices.
Currently, AHRQ supports
approximately nine general evidence
reports per year, in collaboration with
non-federal partners, and 4–10
comparative effectiveness reviews.
Nominations of general topics from nonFederal partners are solicited annually
through a notice in the Federal Register.
However, topic nominations are
accepted on an ongoing basis. All
nominations received in the previous
year as well as topics that were
previously submitted but not selected
are considered for the upcoming year.
Reports and assessments usually
require about 12 months for completion
once assigned to an EPC. AHRQ widely
disseminates the EPC evidence reports
and technology assessments, both
electronically and in print. The EPC
evidence reports, technology
assessments and comparative and
effectiveness reviews do not make
clinical recommendations or
recommendations regarding
reimbursement and coverage policies.
3. Role/Responsibilities of Partners for
General Topics
Nominators of topics selected for
development of an EPC evidence report
assume the role of Partners of AHRQ
and the EPCs. Partners have defined
roles and responsibilities. AHRQ places
high value on these cooperative
relationships, and takes into
consideration a Partner organization’s
past performance of these
responsibilities when considering
whether to accept additional topics
nominated by that organization in
subsequent years. Specifically, Partners
are expected to serve as resources to
EPCs as they develop the evidence
reports related to the nominated topic;
serve as external peer reviewers of
relevant draft evidence reports and
assessments; and commit to timely
translation of the EPC reports and
assessments into their town quality
improvement tolls (e.g., clinical practice
VerDate Aug<31>2005
19:39 Apr 16, 2007
Jkt 211001
guidelines, performance measures),
educational programs, or reimbursement
policies; and dissemination of these
derivative products to their membership
or other health care stakeholders, as
appropriate. AHRQ also is interested in
all the uses of these derivative products
and the products’ impact on enhanced
health care. AHRQ looks to its Partners
to provide use and impact data on
products that are based on EPC evidence
reports and technology assessments.
4. Topics for Reports
The EPCs prepare evidence reports,
technology assessments, and
comparative and effectiveness reviews
on topics for which there is significant
demand for information by health care
providers, insurers, purchasers, healthrelated societies, and patient advocacy
organizations. Such topics may include
the prevention, diagnosis and/or
treatment of particular clinical and
behavioral conditions, use of alternative
or complementary therapies, and
appropriate use of commonly provided
services, procedures, or technologies.
Topics also may include issues related
to the organization and financing of care
such as risk adjustment methodologies,
market performance measures, provider
payment mechanisms, and insurance
purchasing tools, as well as
measurement or evaluation of provider
integration of new scientific findings
regarding health care and delivery
innovations. Previous reports and
reviews can be found at https://
www.ahrg.gov/clinic/epcix.htm and
https://effectivehealthcare.ahrg.gov/
products/progress.cfm.
AHRQ is very interested in receiving
topic nominations from professional
societies and organizations composed of
members of minority populations, as
well as topic nominations that have
significant impact on AHRQ priority
populations including low income
groups, minority groups, women,
children, the elderly, and individuals
with special health care needs, such as
those with disabilities, those who need
chronic care or end-of-life healthcare, or
those who live in inner-city and rural
areas.
5. Topic Nomination
Nominations of topics for AHRQ
evidence reports, technology
assessments, and comparative
effectiveness reviews should focus on
specific aspects of prevention,
diagnosis, treatment and/or
management of a particular condition;
an individual procedure, treatment, or
technology; or a specific healthcare
organizational or financial strategy. The
processes that AHRQ employs to select
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
clinical and behavioral topics as well as
organization and financing topics
nominated by the EPCs are described
below. For each topic, the nominating
organization must provide the following
information:
A. Rationale and supporting evidence
on the relevance and importance of the
topic;
B. Three to five focused questions on
the topic to be addressed;
C. Plans for rapid translation of the
evidence reports and technology
assessments into clinical guidelines,
performance measures, educational
programs, or other strategies for
strengthening the quality of health care
services, or plans to inform
development of reimbursement or
coverage policies;
D. Plans for use and/or dissemination
of these derivative products, e.g., to
membership and others, if appropriate;
and,
E. Process by which the nominating
organization will measure the use of
these products and impact of such use.
6. Topic Selection
Factors that will be considered in the
selection of topics for AHRQ evidence
reports, technology assessments, and
comparative and effectiveness reviews
and which should/may be addressed in
nomination material, include:
A. Burden of related disease(s)
including severity, incidence and/or
prevalence or relevance of the
organizational/financial topic to the
general population and/or AHRQ’s or
the Secretary’s priorities which are
available at https://
www.effectivehealthcare.ahrq.gov;
B. Total costs associated with a
condition, procedure, treatment,
technology, or organization/financial
topic taking into account the number of
people needing such care, the unit cost
of care, and related or indirect costs;
C. Relevance to the needs of the
Medicare, Medicaid and other Federal
healthcare programs;
D. Controversy or uncertainty about
the topic and availability of scientific
data to support the systematic review
and analysis of the topic;
E. Potential for reducing clinically
significant variations in the prevention,
diagnosis, treatment, or management of
a disease or condition; or in changing
the use of a procedure or technology;
informing and improving patient and/or
provider decisionmaking; improving
health outcomes; and/or reducing costs;
and,
F. Nominating organization’s plan to
disseminate derivative products,
measure use and impact of these
products on outcomes, or otherwise
E:\FR\FM\17APN1.SGM
17APN1
19205
Federal Register / Vol. 72, No. 73 / Tuesday, April 17, 2007 / Notices
incorporate the report into its
managerial or policy decision making.
7. Submission of Nominations
Topics nominations for general topics
should be submitted to Beth A. Collins
Sharp, PhD, R.N., Director, Evidencebased Practice Centers (EPC) Program,
Center for Outcomes and Evidence,
AHRQ, 540 Gaither Road, Rockville, MD
20850. Electronic submissions to
epc@ahrq.gov are preferred. Topic
nominations for comparative
effectiveness reviews should be
submitted to https://
www.effectivehealthcare.ahrq.gov.
Dated: April 5, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–1813 Filed 4–16–07; 8:45 am]
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Centers for Disease Control and
Prevention
Indicators of the Performance of Local
and State and Education Agencies in
HIV-prevention and Coordinated School
Health Program Activities for
Adolescent and School Health Programs
(0920–0672)—(Extension)—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
[60Day–07–0672]
Background and Brief Description
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Joan Karr, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
The proposed project is an annual
Web-based questionnaire to assess
programmatic activities among local
education agencies (LEA) and state and
territorial education agencies (SEA and
TEA) funded by the Division of
Adolescent and School Health (DASH),
Centers for Disease Control and
Prevention.
Currently, there is no standardized
annual reporting process for HIV
prevention activities or coordinated
school health program (CSHP) activities
among LEAs and SEAs/TEAs funded by
DASH. Data being gathered will be in
the form of four questionnaires, which
will: (1) Provide standardized
information about how HIV prevention,
asthma management, and CSHP funds
are used by LEAs and SEAs; (2) assess
the extent to which programmatic
adjustments are indicated; (3) provide
descriptive and process information
about program activities; and (4)
provide greater accountability for use of
public funds. These questionnaires are
to be completed within ninety days after
the end of the fiscal year by the DASHfunded partners on a Web site managed
by DASH.
Of the four Web-based questionnaires
corresponding to the specific funding
source: Two (2) questionnaires will
pertain to HIV-prevention program
activities among LEAs and SEAs/TEAs;
one (1) will pertain to asthma
management activities among LEAs; and
one (1) will pertain to CSHP activities
among SEAs.
The HIV questionnaires will include
questions on:
• Distribution of, professional
development and individualized
technical assistance on school policies.
• Distribution of professional
development and individualized
technical assistance on education
curricula and instruction.
• Distribution of professional
development and individualized
technical assistance assessment on
student standards.
• Collaboration with external
partners.
• Targeting priority populations.
• Planning and improving projects.
• Information about additional
program activities.
The asthma questionnaire will ask the
questions above, but will focus on
asthma management activities.
The CSHP questionnaire will also ask
the questions above, but focused on
physical activity, nutrition, and tobaccouse prevention activities (PANT), and
include additional questions on:
• Joint activities of the State
Education Agency and State Health
Agency (SHA).
• Activities of the CSHP state-wide
coalition.
• Health promotion programs and
environmental approaches to PANT.
There are no costs to respondents
except their time to participate in the
survey.
ESTIMATED ANNUALIZED BURDEN HOURS
sroberts on PROD1PC70 with NOTICES
Form name
HIV—Local Education Agency (LEA) Official.
State & Territorial Educational Agency (SEA &
TEA) Officials.
Asthma—Local Educational
Agency (LEA) Officials.
Indicators for School Health
Programs: HIV Prevention.
Indicators for School Health
Programs: HIV Prevention.
VerDate Aug<31>2005
19:39 Apr 16, 2007
PO 00000
Frm 00041
Average burden
per response
(in hours)
Total burden
(in hours)
18
7.2
129
1
7.2
396
10
Fmt 4703
1
55
Indicators for School Health
Programs: Asthma Management.
Jkt 211001
Number of responses
per respondent
Number of
respondents
Respondents
1
7.2
72
Sfmt 4703
E:\FR\FM\17APN1.SGM
17APN1
Agencies
[Federal Register Volume 72, Number 73 (Tuesday, April 17, 2007)]
[Notices]
[Pages 19203-19205]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1813]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Nominations of Topics for Evidence-based Practice Centers
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Nomination of topics for evidence reports, technology
assessments, and comparative and effectiveness reviews.
-----------------------------------------------------------------------
SUMMARY: AHRQ invites nominations of topics for evidence reports,
technology assessments, and comparative and effectiveness reviews
conducted by its Evidence-based Practice Centers (EPC) Program relating
to the prevention, diagnosis, treatment and management of common
diseases and clinical conditions, as well as topics relating to the
organization and financing of health care. Previous evidence reports
and comparative effectiveness reviews can be found at https://
www.ahrq.gov/clinic/epcix.htm and https://effectivehealthcare.ahrq.gov/
products/progress.cfm, respectively.
DATES: Topic nominations for general evidence reports should be
submitted by May 14, 2007, in order to be considered for fiscal year
2007 selection. Topic nominations for comparative and effectiveness
reviews are accepted on an on going basis at: https://
effectivehealthcare.ahrq.gov/topicNomination/nominationsForm.cfm. In
addition to timely responses to this request for nominations, AHRQ also
accepts topic nominations on an ongoing basis for consideration for
future years. Topics submitted for consideration as general evidence
reports will concurrently be considered as comparative effectiveness
reviews as appropriate. AHRQ will not reply to individual responses,
but will consider all nominations during the selection process. Those
who submit topics that are selected will be notified by AHRQ.
ADDRESSES: Topics nominations should be submitted to Beth A. Collins
Sharp, Ph.D., R.N., Director, Evidence-based Practice Centers (EPC)
Program, Center for Outcomes and Evidence, AHRQ, 540 Gaither Road,
Rockville, MD 20850. Electronic submissions to epc@ahrq.gov are
preferred.
FOR FURTHER INFORMATION CONTACT: Beth A. Collins Sharp, Ph.D., R.N.,
Center for Outcomes and Evidence, AHRQ, 540 Gaither Road, Rockville, MD
20850; Phone: (301) 427-1503; Fax: (301) 427-1640; E-mail:
beth.collinssharp@ahrq.hhs.gov.
Arrangement for Public Inspection: All nominations will be
available for public inspection by appointment at the Center for
Outcomes and Evidence, telephone (301) 427-1600, weekdays between 8:30
a.m. and 5 p.m. (Eastern time).
SUPPLEMENTARY INFORMATION:
1. Background
Under Title IX of the Public Health Service Act, AHRQ is charged
with enhancing the quality, appropriateness, and effectiveness of
health care services and access to such services. AHRQ accomplishes
these goals through scientific research, including evaluative medical
literature reviews and technology assessments, and through the
promotion of improvements in clinical practice and health systems
practices.
2. Purpose and Overview
The purpose of this notice is to solicit topic nominations for
evidence reports, technology assessments, and comparative and
effectiveness reviews. Professional societies, health systems,
employers, insurers, providers, and consumer groups are encouraged to
nominate topics and then collaborate with AHRQ, as it carries out its
mission to promote the practice of evidence-based health care. In this
endeavor, AHRQ serves as a science partner with private-sector and
public organizations in their efforts to improve the quality,
effectiveness, and appropriateness of health care delivery in the
United States, and to expedite the translation of evidence-based
research findings into improved health care services. To undertake
scientific analyses and evidence syntheses on topics of high priority
to its public and private health care partners and the health care
community generally, AHRQ awards task order contracts to its Evidence-
based Practice Centers (EPCs).
The EPCs produce systematic reviews of the scientific literature--
evidence reports, technology assessments, and comparative and
effectiveness reviews--that provide to public and private organizations
the foundation for developing and implementing their own practice
guidelines, performance
[[Page 19204]]
measures, educational programs, and other strategies to improve the
quality of health care and decision-making related to the effectiveness
and appropriateness of specific health care technologies and services.
The evidence reports, technology assessments, and comparative and
effectiveness reviews also may be used to inform coverage and
reimbursement policies. As the body of scientific studies related to
organization and financing of health care grows, systematic review and
analysis of these studies, in addition to clinical and behavioral
research, can provide health system organizations with a scientific
foundation for developing or improving system-wide policies and
practices.
Currently, AHRQ supports approximately nine general evidence
reports per year, in collaboration with non-federal partners, and 4-10
comparative effectiveness reviews. Nominations of general topics from
non-Federal partners are solicited annually through a notice in the
Federal Register. However, topic nominations are accepted on an ongoing
basis. All nominations received in the previous year as well as topics
that were previously submitted but not selected are considered for the
upcoming year.
Reports and assessments usually require about 12 months for
completion once assigned to an EPC. AHRQ widely disseminates the EPC
evidence reports and technology assessments, both electronically and in
print. The EPC evidence reports, technology assessments and comparative
and effectiveness reviews do not make clinical recommendations or
recommendations regarding reimbursement and coverage policies.
3. Role/Responsibilities of Partners for General Topics
Nominators of topics selected for development of an EPC evidence
report assume the role of Partners of AHRQ and the EPCs. Partners have
defined roles and responsibilities. AHRQ places high value on these
cooperative relationships, and takes into consideration a Partner
organization's past performance of these responsibilities when
considering whether to accept additional topics nominated by that
organization in subsequent years. Specifically, Partners are expected
to serve as resources to EPCs as they develop the evidence reports
related to the nominated topic; serve as external peer reviewers of
relevant draft evidence reports and assessments; and commit to timely
translation of the EPC reports and assessments into their town quality
improvement tolls (e.g., clinical practice guidelines, performance
measures), educational programs, or reimbursement policies; and
dissemination of these derivative products to their membership or other
health care stakeholders, as appropriate. AHRQ also is interested in
all the uses of these derivative products and the products' impact on
enhanced health care. AHRQ looks to its Partners to provide use and
impact data on products that are based on EPC evidence reports and
technology assessments.
4. Topics for Reports
The EPCs prepare evidence reports, technology assessments, and
comparative and effectiveness reviews on topics for which there is
significant demand for information by health care providers, insurers,
purchasers, health-related societies, and patient advocacy
organizations. Such topics may include the prevention, diagnosis and/or
treatment of particular clinical and behavioral conditions, use of
alternative or complementary therapies, and appropriate use of commonly
provided services, procedures, or technologies. Topics also may include
issues related to the organization and financing of care such as risk
adjustment methodologies, market performance measures, provider payment
mechanisms, and insurance purchasing tools, as well as measurement or
evaluation of provider integration of new scientific findings regarding
health care and delivery innovations. Previous reports and reviews can
be found at https://www.ahrg.gov/clinic/epcix.htm and https://
effectivehealthcare.ahrg.gov/products/progress.cfm.
AHRQ is very interested in receiving topic nominations from
professional societies and organizations composed of members of
minority populations, as well as topic nominations that have
significant impact on AHRQ priority populations including low income
groups, minority groups, women, children, the elderly, and individuals
with special health care needs, such as those with disabilities, those
who need chronic care or end-of-life healthcare, or those who live in
inner-city and rural areas.
5. Topic Nomination
Nominations of topics for AHRQ evidence reports, technology
assessments, and comparative effectiveness reviews should focus on
specific aspects of prevention, diagnosis, treatment and/or management
of a particular condition; an individual procedure, treatment, or
technology; or a specific healthcare organizational or financial
strategy. The processes that AHRQ employs to select clinical and
behavioral topics as well as organization and financing topics
nominated by the EPCs are described below. For each topic, the
nominating organization must provide the following information:
A. Rationale and supporting evidence on the relevance and
importance of the topic;
B. Three to five focused questions on the topic to be addressed;
C. Plans for rapid translation of the evidence reports and
technology assessments into clinical guidelines, performance measures,
educational programs, or other strategies for strengthening the quality
of health care services, or plans to inform development of
reimbursement or coverage policies;
D. Plans for use and/or dissemination of these derivative products,
e.g., to membership and others, if appropriate; and,
E. Process by which the nominating organization will measure the
use of these products and impact of such use.
6. Topic Selection
Factors that will be considered in the selection of topics for AHRQ
evidence reports, technology assessments, and comparative and
effectiveness reviews and which should/may be addressed in nomination
material, include:
A. Burden of related disease(s) including severity, incidence and/
or prevalence or relevance of the organizational/financial topic to the
general population and/or AHRQ's or the Secretary's priorities which
are available at https://www.effectivehealthcare.ahrq.gov;
B. Total costs associated with a condition, procedure, treatment,
technology, or organization/financial topic taking into account the
number of people needing such care, the unit cost of care, and related
or indirect costs;
C. Relevance to the needs of the Medicare, Medicaid and other
Federal healthcare programs;
D. Controversy or uncertainty about the topic and availability of
scientific data to support the systematic review and analysis of the
topic;
E. Potential for reducing clinically significant variations in the
prevention, diagnosis, treatment, or management of a disease or
condition; or in changing the use of a procedure or technology;
informing and improving patient and/or provider decisionmaking;
improving health outcomes; and/or reducing costs; and,
F. Nominating organization's plan to disseminate derivative
products, measure use and impact of these products on outcomes, or
otherwise
[[Page 19205]]
incorporate the report into its managerial or policy decision making.
7. Submission of Nominations
Topics nominations for general topics should be submitted to Beth
A. Collins Sharp, PhD, R.N., Director, Evidence-based Practice Centers
(EPC) Program, Center for Outcomes and Evidence, AHRQ, 540 Gaither
Road, Rockville, MD 20850. Electronic submissions to epc@ahrq.gov are
preferred. Topic nominations for comparative effectiveness reviews
should be submitted to https://www.effectivehealthcare.ahrq.gov.
Dated: April 5, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07-1813 Filed 4-16-07; 8:45 am]
BILLING CODE 4160-90-M